Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ProQR Therapeutics N.V (PRQR) Short-term Investments: 2021-2024

Historic Short-term Investments for ProQR Therapeutics N.V (PRQR) over the last 4 years, with Dec 2024 value amounting to $500.10.

  • ProQR Therapeutics N.V's Short-term Investments rose 590.74% to $341.36 in Q3 2025 from the same period last year, while for Sep 2025 it was $341.36, marking a year-over-year increase of 590.74%. This contributed to the annual value of $500.10 for FY2024, which is 48.66% up from last year.
  • According to the latest figures from FY2024, ProQR Therapeutics N.V's Short-term Investments is $500.10, which was up 48.66% from $336.41 recorded in FY2023.
  • In the past 5 years, ProQR Therapeutics N.V's Short-term Investments registered a high of $4.7 million during FY2021, and its lowest value of $336.41 during FY2023.
  • In the last 3 years, ProQR Therapeutics N.V's Short-term Investments had a median value of $500.10 in 2024 and averaged $429,803.
  • Its Short-term Investments has fluctuated over the past 5 years, first crashed by 99.97% in 2023, then spiked by 48.66% in 2024.
  • Over the past 4 years, ProQR Therapeutics N.V's Short-term Investments (Yearly) stood at $4.7 million in 2021, then plummeted by 72.74% to $1.3 million in 2022, then crashed by 99.97% to $336.41 in 2023, then skyrocketed by 48.66% to $500.10 in 2024.